Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Ardelyx, a pharmaceutical company, has posted new job openings for positions such as Associate Director of Quality Management Systems, Medical Writer, Senior Administrative Assistant, and Associate Director of Health Economics and Outcomes Research. These roles involve responsibilities such as leading process improvements, developing clinical documentation, providing administrative support, and generating real-world evidence and health economics analyses. The company seems to be expanding its team and focusing on various aspects of its operations.